Daré Bioscience, Inc. (DARE) Q4 2024 Earnings Call Transcript

Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET

Company Participants

MarDee Haring-Layton – Chief Accounting Officer
Sabrina Martucci Johnson – President & Chief Executive Officer

Conference Call Participants

Catherine Novack – Jones Trading
Douglas Tsao – H.C. Wainwright
Kemp Dolliver – Brookline Capital Markets

Operator

Welcome to the conference call hosted by Daré Bioscience to review the company’s 2024 Financial Results and to provide a Business Update. This call is being recorded. My name is Jericho, and I’ll be your operator today. With us today from Daré are Sabrina Martucci Johnson, President and Chief Executive Officer, and MarDee Haring-Layton, Chief Accounting Officer.

Ms. Haring-Layton, please proceed.

MarDee Haring-Layton

Good afternoon and welcome to the Daré Bioscience financial results and business update call for the year ended December 31, 2024. Today, we will review our results, discuss developments and expectations for our pipeline and portfolio and discuss our expanded business strategy to include 503B compounding as a dual path approach to bring some of our proprietary formulations to market as soon as practical.

I would like to remind you that today’s discussion will include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that are not statements of historical fact should be considered forward-looking statements.

Actual results or events could differ materially from those anticipated or implied by these statements due to known and unknown risks and uncertainties. You should not place undue reliance on forward-looking statements. Forward-looking statements are qualified in their entirety by the cautionary statements in the company’s SEC filings including our Form 10-K for the year ended December 31 2024, which was filed today.

I would